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In July 2014, the South African (SA) media reported that, by 
proving that low-carbohydrate (CHO) diets were not better than 
‘balanced’ eating,[1] a recently published article[2] from the universities 
of Stellenbosch and Cape Town had effectively ‘debunked the 
Banting diet’.[3] Other reports echoed this sentiment. The Cape Times 
personalised the message: ‘Noakes’s low-carb diet not healthier’, while 
quoting the chief executive of the Heart and Stroke Foundation of 
SA: ‘Based on the current evidence we cannot recommend a low 
carbohydrate diet to the public.’[4]
The claim that a low-CHO diet was no better than balanced eating 
does not ‘debunk’ the low-CHO diet. These reports could as easily 
have stated that eating a balanced diet is no better for producing 
weight loss than eating a low-CHO diet is. This media positioning 
is interesting and particularly important in the current context that 
low-CHO diets have been placed on trial in SA.[5]
More objective reporting of Naude et al.’s[2] systematic review 
should have made two important points:
First, the study could not provide any information about Banting 
or low-CHO diets because it failed to study either. The average 
carbohydrate intake for the 14 studies included in the systematic 
review[6] was 35% (fat 35%; protein 30%).[7-20] This is substantially 
different from the 5% CHO (<50 g/day), moderate protein, and high 
fat, which is the dietary composition of the low-CHO diet promoted 
for the therapeutic management of obesity and type 2 diabetes 
mellitus.[21-23]
Second, the objective of Naude et al.’s[2] article was ‘To compare 
the effects of low (sic) CHO and isoenergetic balanced weight loss 
diets in overweight and obese adults’. As a key effect of the low-
CHO diet is to reduce hunger by increasing satiety despite a reduced 
energy intake,[24] the caloric intake of subjects on the control diet in 
isoenergetic trials must be voluntarily restricted to match this effect. 
This effectively negates the advantage provided by the uniquely 
satiating effect of genuinely low-CHO diets.
Both of these points served to disadvantage the lower-CHO diets 
included by Naude et al.[2] in their systematic review. 
Regarding the first point, the introduction to the Naude et al.[2] 
article confirmed the authors’ understanding of what constitutes a 
low-CHO diet: ‘Some weight loss diets widely promoted through 
the media … recommend a regime greatly restricting carbohydrates 
(CHO).’ The introduction continued: ‘To achieve the very low CHO 
intake, these diets prescribe restriction of most vegetables and fruit 
… .’ Confirming their understanding of what constitutes a low-
CHO diet, the authors proceeded to find against these diets without 
actually studying them. Only 1 of the 19 trials they initially reviewed 
was sufficiently low in CHO to qualify as a trial of the (therapeutic) 
low-CHO diet.[13] The other 18 trials reviewed were lower in CHO 
content than current public health dietary guidelines, but they were 
not low-CHO diets. There is a substantial difference between lower- 
(than dietary guidelines) and therapeutically low-CHO diets. The 
therapeutic low-CHO diet is prescribed specifically to lower the daily 
CHO intake to <50 g/day, which is the level at which optimal benefits 
of this dietary intervention occur.[22]
In view of the pivotal importance of this article to the conduct of 
the ‘trial’ against low-CHO diets in SA, we considered it important 
to submit the article to a rigorous re-analysis. In the course of our 
investigation we uncovered a multitude of errors that materially 
altered the conclusions promoted by the article. 
In the context of the current debate on low-CHO diets in SA, it is 
important that the erroneous messages conveyed to the SA public as a 
result of the inaccuracies in that study[2] should be rectified expedi tiously. 
A re-examination of the Naude et al.[2] 
article
The main conclusion
The main conclusion presented in the abstract of the Naude et al.[2] 
article was: ‘In non-diabetic participants, our analysis showed little or 
no difference in mean weight loss in the two groups at 3 - 6 months.’ 
This conclusion was based on a study of 14 trials that were deemed 
moderate-quality evidence.[7-20]
The studies selected
The inclusion criteria set for the selection of these 14 studies by 
Naude et al.[2] were: randomised controlled trials (RCTs); published 
in English; >10 participants randomised in each group; diet was the 
only intervention; control and intervention diets were isocaloric 
(isoenergetic); complete macronutrient profile of intervention diet 
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was available; control diet was deemed balanced (defined as 45 - 65%, 
25 - 35% and 10 - 20% of total energy from CHO, fat and protein, 
respectively); and the follow-up period was ≥12 weeks.
We started with the assumption that the 14 studies had been 
chosen in good faith. It transpired that the following four studies 
should not have been included:
• Luscombe et al.,[16] as it was a duplication of Farns worth et al.’s[15] article. 
• Keogh et al.[17] and Sacks et al.,[14] as they failed the inclusion 
criteria set by Naude et al.[2] that fat should provide 25 - 35% of the 
energy in a balanced diet. Instead, fat provided only 20% of the 
target calories in the control diets in both those studies.
• De Luis et al.,[9] as the data are not conducive to meta-analysis. 
The two De Luis et al.[8,9] studies are visibly incongruent in Fig. 3 
of the Naude et al.[6] article (Supplemental material 1: Table 4*). 
Fig. 3 reported weight data from the end of the trial (but without 
data on weight at the start of the trial), when weight loss during 
the trial was the target outcome. The error of including these 
data is inexplicable. The study of De Luis et al.[9] cannot be used 
in meta-analysis, as the study did not report standard deviation 
(SD) data for the weight losses in the diet and control groups. 
However, the data of De Luis et al.[8] can be used in meta-analysis. 
We extracted the weight loss and SD data from De Luis et al.,[8] as 
Naude et al.[2] should have done for consistency with their other 
methods of data extraction (Supplemental material 1: Table 6*).
The meta-analysis sub-grouping
Naude et al.[6] split the 14 studies into so-called ‘high fat variants’ and 
‘high protein variants’. Neither achieved a significant result. However, 
this split was not justified. Sub-grouping may be undertaken in 
meta-analysis when two different interventions are being compared, 
e.g. the comparison of the effects of two different drugs v. no drug 
control. The sub-grouping of studies into those deemed ‘high fat’ or 
‘high protein’ was not justified, as Naude et al.’s[2] original objective  
was not to compare high-fat or high-protein diets with balanced 
diets. Their objective was ostensibly to study the effects of ‘low’-CHO 
diets by comparing lower-CHO diets v. balanced diets.
Furthermore, the classification of diets as either high fat or high 
protein by Naude et al.[2] was entirely subjective. To clarify, the 
studies of Frisch et al.[10] and Klemsdal et al.[11] complicated calcula-
tions of the average macronutrient compositions of all the diets, as 
these authors reported only the ranges of macronutrient intakes. 
Frisch et al.[10] reported CHO/fat/protein percentage proportions 
as <40/>35/25 and >55/<30/15 for the diet and control groups, 
respectively. Klemsdal et al.[11] reported CHO/fat/protein percentage 
proportions as 30 - 35/35 - 40/25 - 30 and 55 - 60/<30/15 for diet and 
control groups, respectively. 
We used CHO/fat/protein in percentage proportions of 40/35/25 
and 55/30/15 for the diet and control groups, respectively, in the 
study by Frisch et al.,[10] and 33/38/28 (mid-points rounded up) and 
55/30/15 for the respective groups in the study of Klemsdal et al.,[11] 
to calculate average macronutrient intakes for the 14 studies included 
in the Naude et al.[2] meta-analysis as 35/35/30 for the diet groups and 
56/27/17 for the control groups. Protein intake in the diet groups of 
their so-called low-CHO high-protein (LCHP) and low-CHO high-
fat (LCHF) studies averaged 31.5 - 32.5% and 28.4%, respectively, 
probably a biologically insignificant difference. (The variation in the 
protein proportion for the LCHP group results from macronutrient 
proportions differing in the abstract and narrative of two studies[15-16] 
(Supplemental material 1: Table 2*)). In the studies by Lim et al.[13] 
and Aude et al.[7] there were higher percentage protein intakes than 
in four of the six studies placed in their high-protein group.[15,16,18,19] 
Additionally, if the four studies were excluded that should have been 
excluded,[9,14,16,17] the protein differential narrows even further to 
31.3% and 29.3% for so-called LCHP and LCHF, respectively. The 
sub-grouping was therefore not necessary, not justified and not robust.
Errors in data extraction
The primary claim emanating from the Naude et al.[2] article was that there 
was little or no difference in mean weight loss between a lower-CHO diet 
and a so-called balanced diet. This was the only part of the article that we 
re-examined. We found tens of errors in this re-examination. These are 
fully detailed in the Supplemental material 1: Tables 1 - 6.* The material 
errors that we detected are summarised as follows: 
• The findings in the studies by Frisch et al.,[10] Layman et al.,[19] 
Lim et al.[13] and Wycherley et al.[20] all favoured the lower-CHO 
intervention. For all of these studies, Naude et al.[2] reported the 
number of completers in the study at a time later than that at which 
the weight loss data they included had been recorded. This resulted 
in lower weighting being assigned to these studies in meta-analysis, 
as these studies would appear to include fewer participants than 
was the case. This would have disadvantaged the overall pooled 
effect for lower-CHO diets.
• The study of Wycherley et al.[20] included weight loss data for 52 weeks 
of the trial. Naude et al.[2] reported that they had used those data, but 
they did not. Instead, they used data from 12 weeks of the study. Use of 
the 52-week data would have favoured the lower-CHO intervention. 
• Krauss et al.[12] illustrated the macronutrient compositions of four 
different diets. Three diets differed in macronutrient composition, 
but not in saturated fatty acids (SFAs) and were marked as planned 
(a priori) comparisons. The CHO content of these three were 54%, 
39% and 26%, respectively. The fourth diet also contained 26% 
CHO, but was reported as high in SFA and marked as intended to 
be compared with the 26% CHO/low-SFA diet alone. Naude et al.[2] 
compared the 26% high-SFA diet with the balanced low-SFA diet, 
which unnecessarily introduced a second variable and was to the 
disadvantage of the direct comparison between the lower-CHO and 
the balanced diet. 
• The studies by Farnsworth et al.[15] and Luscombe et al.[16] were a 
duplication of the same study. Both studies favoured the control 
balanced dietary intervention. Furthermore, the weight loss in the 
control diet intervention was reported by Naude et al.[2] as 7.95 kg, 
rather than the 7.9 kg actually reported by Farnsworth et al.[15]
• The use of end-value data for body weight, not weight loss, in 
the De Luis et al.[8,9] studies was absurd and favoured the control 
balanced dietary intervention. 
• The weight loss data for the study by Krauss et al.[12] as reported by 
Naude et al.[2] recorded equal weight losses for the diet and control 
groups. Those specific data could not be found in the original pub-
lication. Instead, the actual data reported by Krauss et al.[12] slightly 
favoured the lower-CHO diet intervention.
• The study by Sacks et al.[14] should not have been included, as it 
did not meet Naude et al.’s[2] criteria for inclusion. Having been 
included, the data for weight loss appear to have been reported the 
wrong way round so that the slightly higher weight loss occurring 
in the lower-CHO diet was incorrectly assigned to the control diet.
• The study by Keogh et al.[17] similarly failed Naude et al.’s[2] inclusion 
criteria, but the data for weight loss in that study slightly favoured 
the lower-CHO diet intervention. However, the data for the number 
of completers were taken at the end of the study, whereas the data 
for weight loss were from an earlier part of the trial. This mitigated 
some of any advantage afforded to the lower-CHO diet intervention.
All errors made, except for part of the last one listed,[17] favoured the 
control group. 
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Study limitations
A number of the studies were not designed to evaluate weight loss as 
their primary objective. The study of De Luis et al.[9] was designed to 
study two different hypocaloric diets on the secretion of glucagon-like 
peptide 1. Another study by De Luis et al.[8] evaluated weight loss and 
blood adipocytokine concentrations in obese subjects with a genetic 
variant. Keogh et al.[17] studied flow-mediated dilatation, adhesion 
molecules and adiponectin after weight loss. The primary aim of the 
Klemsdal et al.[11] study was to evaluate the impact of low glycaemic 
load v. low-fat diets in people with and without the metabolic 
syndrome. Krauss et al.[12] sought to study the effects of reduced CHO 
intake and weight loss on atherogenic dyslipidaemia. Lasker et al.[18] 
studied the metabolic effects of two different weight loss diets on 
dyslipidaemia and post-prandial insulin responses to a meal.
A number of the studies lacked generalisability to whole popula-
tions. Wycherley et al.[20] and Krauss et al.[12] studied males only. 
Farnsworth et al.[15] and Luscombe et al.[16] (noting that these are 
duplicate studies) studied men and women with insulin resistance and 
hyperinsulinaemia. De Luis et al.[8] included only obese subjects with 
the rs9939609 genetic variant. 
A number of the authors did not consider their interventions to be 
low-CHO diets. Lasker et al.[18] and Layman et al.[19] described their 
interventions as moderate-protein diets. The diet in Lasker et al.’s[18] 
study was additionally reported as ‘moderate carbohydrate’, whereas 
Farnsworth et al.[15] and Luscombe et al.[16] (duplicate studies) con-
sidered their interventions to be high-protein diets. The studies 
by De Luis et al.[8,9] were described as hypocaloric. Frisch et al.[10] 
reported that their study contrasted the effects of CHO-reduced-
intake and fat-reduced-intake diets. Wycherley et al.[20] considered 
their study to be a 52-week comparison of either high-protein or 
high-CHO diets.
In addition, the four studies[25-28] reviewed by Naude et al.[2] to 
compare lower-CHO diets with balanced diets in overweight and 
obese adults with type 2 diabetes were of concern. We ask ourselves 
how interventions recommending a 40% CHO intake to participants 
who cannot metabolise carbohydrate effectively because they have 
diabetes mellitus type 2 were granted ethical approval. 
A revised meta-analysis
Notwithstanding that the Naude et al.[2] article: (i) did not review 
genuinely low-CHO diets; and (ii) introduced an isocaloric inclusion 
criterion, which negated the natural advantage of low-CHO diets, to 
be robust in our re-examination we re-conducted the meta-analysis 
without the errors made by Naude et al.[2] 
The meta-analysis was repeated for the 10 studies that could be 
included in this analysis according to the authors’ own selection criteria 
(Supplemental material 2: Meta-analysis, Fig. 1*). Heterogeneity was 
evaluated using the Q-value, I² and T² calculations. Analyses were 
performed using Comprehensive Meta-Analysis version 2 (Biostat, 
USA). The overall pooled effect was calculated using random effects 
meta-analysis. The standard difference in means was significant at 
−0.272 (95% confidence interval −0.506, −0.039).
In conclusion, when meta-analysis was performed on the 10 studies 
that qualified for inclusion in the study of Naude et al.[2] using their 
own criteria, the data confirmed that the lower-CHO diet produced 
significantly greater weight loss than did the balanced diet.
Discussion
The findings of the Naude et al.[2] meta-analysis were widely reported 
in the SA media as disproof of the overall value of the LCHF diet. 
Indeed, some reports misused this messaging to warn about the 
‘dangerous’ nature of low-CHO diets. 
The objective of our re-examination was to test whether or not 
the findings of the Naude et al.[2] article were robust. We have 
demonstrated that they were not. The main limitation of our article 
is that we re-examined only one part of Naude et al.’s[2] article. We 
found their analysis of the weight loss data to have many errors and 
those errors to have made a material difference to the conclusions. 
Given the number of errors we detected in that single section of the 
article, it is inconceivable that the remainder of the article is robust. 
Therefore, without the need to examine all sections of the article, we 
have shown that in its published form, it is not robust and cannot be 
relied on.
We additionally showed that, notwithstanding two features of the 
study, which by design or by chance disadvantaged low-CHO diets, 
had the Naude et al.[2] meta-analysis been properly performed, it 
would have concluded that the lower-CHO diet produced greater 
weight loss than the balanced diet. This would have radically altered 
the nature of the message heard across SA after its publication and 
might have influenced the eagerness of SA medical authorities to put 
the LCHF/Banting diet on public ‘trial’.
A reasonable question to ask is: how could the published meta-
analysis have included so many errors and have come to the incorrect 
conclusion despite peer review? Another reasonable question to 
ask is: what is the chance that essentially all these errors favoured 
the so-called balanced diet and disadvantaged the lower-CHO diet, 
especially when many of the authors of this article are on public 
record as being vigorously opposed to lower- or low-CHO diets and 
to those who promote such eating plans?
*Supplemental material. Supplemental material 1: Tables 1 - 6, and Supple-
mental material 2: Meta-analysis, are available from the corresponding 
author on request.
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